Contact Us

Chardan’s 5th Annual Genetic Medicines Manufacturing Summit

April 26, 2021

Cell and gene therapy: The next frontier in pharmaceutical services

CBM are part of a new wave of Cell and Gene Therapy companies

The Discovery Labs, another new services company, has some similarities to ElevateBio. The Philadelphia-area venture is perhaps more like BioCentriq, a university-based services firm now opening in New Jersey. But there are differences.

These three companies and others like them are directing their services at the burgeoning cell and gene therapy industry. In the process, they are helping create a completely new branch of the pharmaceutical CDMO world. They will be competing with one another and with a handful of giant services firms that are also investing in the cell and gene therapy sector…

Read full story

April 18, 2021

Why Philadelphia is Poised to Become a Top Cell and Gene Therapy Cluster

The Discovery Labs, The Center for Breakthrough Medicines, and many other companies are betting that Philadelphia is poised to become a world-leading Cell and Gene Therapy Cluster.

Audrey Greenberg, Co-Founder and Executive Director of The Discovery Labs in Philadelphia, touted the advantages for companies found in the ecosystem known as “Cellicon Valley“, and predicted the city could become one of the most important hubs for the biopharma industry in the world. The Discovery Labs’ 2.4 million square foot site in King of Prussia, PA provides all the necessary ingredients to accelerate speed to market for cell and gene therapy innovators. The Center for Breakthrough Medicines is a cell and gene therapy contract development and manufacturing organization (CDMO) for plasmid DNA, viral vectors, and cellular therapy products and is located on-site…

Read full story

April 2, 2021

The Center For Breakthrough Medicines’ Newest Leaders Talk Advanced Therapy Development Manufacturing

The Center for Breakthrough Medicines (CBM) is a fully integrated cell and gene therapy contract development and manufacturing organization

The Center for Breakthrough Medicines (CBM) is a fully integrated cell and gene therapy contract development and manufacturing organization (CDMO) that enables rapid development and commercialization of advanced therapies. Their single-site approach helps customers to accelerate speed to market while mitigating risk via robust platform technologies, advanced supporting analytics, and integrated program and supply chain management. Their vision and execution are supported by a first-class team of seasoned scientists and biopharmaceutical leaders with a unique approach to CDMO relationships that put the client and patient first…

Read full story

April 1, 2021